Showing 16,381 - 16,400 results of 108,226 for search '(( a de decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.78s Refine Results
  1. 16381

    Backbone RMSD of mutant D314N throughout a 100ns MD simulation. by Bruna Baumgarten Krebs (3153162)

    Published 2016
    “…<p>To confirm that mutant D314N stayed stable with an RMSD of 0.6nm, we carried a 100ns MD simulation. The mutant seemed to stabilize at 12ns with an RMSD of 0.5nm, but an increase is noticeable at 40ns, when the backbone RMSD achieves 0.6nm. …”
  2. 16382

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  3. 16383

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  4. 16384
  5. 16385

    DataSheet_1_Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.pdf by Ikechukwu B. Jacob (18253300)

    Published 2024
    “…Pre-incubation of SARS-CoV-2 (Delta) with human SP-A inhibited virus binding and entry and reduced viral load in human lung epithelial cells, evidenced by the dose-dependent decrease in viral RNA, nucleocapsid protein (NP), and titer (p<0.01). …”
  6. 16386
  7. 16387
  8. 16388
  9. 16389
  10. 16390
  11. 16391
  12. 16392
  13. 16393

    Targeted DNA demethylation in human cells by fusion of a plant 5-methylcytosine DNA glycosylase to a sequence-specific DNA binding domain by Jara Teresa Parrilla-Doblas (3825424)

    Published 2017
    “…In contrast, plants use specific DNA glycosylases that directly excise 5mC and initiate its substitution for unmethylated C in a base excision repair process. …”
  14. 16394
  15. 16395

    Image_5_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIF by Jian Wu (41301)

    Published 2021
    “…As a stable indicator, the changes in IL-6 levels could indicate the inflammatory conditions during a viral infection. …”
  16. 16396

    DataSheet1_Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis.DOCX by Huifang Xu (111603)

    Published 2022
    “…The model of the five-mRNA biomarker signature was successfully verified on a testing set and independent sets. …”
  17. 16397
  18. 16398

    Supplementary Material for: Novel digenic variants in COL4A4 and COL4A5 causing X-linked Alport Syndrome by Uedono H. (10917012)

    Published 2024
    “…The number of cases of digenic AS has increased, but the genotype-phenotype correlation of patient with digenic AS is still unclear. Here, we present a case of digenic AS with novel digenic missense variants in COL4A4 (c.827G>C, p.Gly276Ala) and COL4A5 (c.4369G>C, p.Gly1457Arg). …”
  19. 16399

    DataSheet_5_Hypothyroidism has a protective causal association with hepatocellular carcinoma: A two-sample Mendelian randomization study.pdf by Likui Lu (6631655)

    Published 2022
    “…There were no statistical indications of heterogeneity among instruments (P-het = 0.667). Across five MR methods, genetically predicted hypothyroidism shows a consistent correlation with HCC. …”
  20. 16400

    Supplementary Material for: Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency by Muthuvel G. (14430801)

    Published 2023
    “…Introduction: The metalloproteinase pregnancy-associated plasma protein A2 (PAPP-A2) cleaves insulin-like growth factor (IGF) binding proteins 3 and 5 to release bioactive IGF-I from its ternary complex. …”